Showing results (11-20 of 196) with videos related to

Sort By:
Pageof 20
Current Protein & Peptide Science|December 8, 2004
Alpha-interferon and its effects on signalling pathways within cellsMichele Caraglia, Giovanni Vitale, Monica Marra, et al.
Cancers|April 3, 2021
Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' HeelDaniele Caracciolo, Caterina Riillo, Maria Teresa Di Martino, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 8, 2016
Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancerDomenico Ciliberto, Nicoletta Staropoli, Silvia Chiellino, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2006
Genetics and molecular profiling of multiple myeloma: novel tools for clinical management?Pierfrancesco Tassone, Pierosandro Tagliaferri, Marco Rossi, et al.
EURASIP Journal on Bioinformatics & Systems Biology|February 15, 2017
Analysis of miRNA, mRNA, and TF interactions through network-based methodsPietro H Guzzi, Maria Teresa Di Martino, Pierosandro Tagliaferri, et al.
Oncotarget|May 8, 2018
Mouse models of multiple myeloma: technologic platforms and perspectivesMarco Rossi, Cirino Botta, Mariamena Arbitrio, et al.
Current Pharmaceutical Design|March 14, 2007
Novel therapeutic approaches based on the targeting of microenvironment-derived survival pathways in human cancer: experimental models and translational issuesPierfrancesco Tassone, Pierosandro Tagliaferri, Maria Teresa Fulciniti, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
EGF-R small inhibitors and anti-EGF-R antibodies: advantages and limits of a new avenue in anticancer therapyMichele Caraglia, Monica Marra, Giuseppina Meo, et al.
Molecular Therapy. Nucleic Acids|March 9, 2020
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley RatsMaria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, et al.
Current Drug Targets|July 10, 2013
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenarioMarco Rossi, Nicola Amodio, M T Di Martino, et al.
Pageof 20